BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 12137718)

  • 21. Procaine treatments for cognition and dementia.
    Szatmári S; Bereczki D
    Cochrane Database Syst Rev; 2008 Oct; (4):CD005993. PubMed ID: 18843698
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ginseng for cognition.
    Geng J; Dong J; Ni H; Lee MS; Wu T; Jiang K; Wang G; Zhou AL; Malouf R
    Cochrane Database Syst Rev; 2010 Dec; (12):CD007769. PubMed ID: 21154383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy and cognition: systematic review and meta-analysis.
    LeBlanc ES; Janowsky J; Chan BK; Nelson HD
    JAMA; 2001 Mar; 285(11):1489-99. PubMed ID: 11255426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ginkgo biloba for cognitive impairment and dementia.
    Birks J; Grimley EV; Van Dongen M
    Cochrane Database Syst Rev; 2002; (4):CD003120. PubMed ID: 12519586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.
    Espeland MA; Rapp SR; Shumaker SA; Brunner R; Manson JE; Sherwin BB; Hsia J; Margolis KL; Hogan PE; Wallace R; Dailey M; Freeman R; Hays J;
    JAMA; 2004 Jun; 291(24):2959-68. PubMed ID: 15213207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WITHDRAWN: Dehydroepiandrosterone (DHEA) supplementation for cognitive function.
    Huppert FA; Van Niekerk JK
    Cochrane Database Syst Rev; 2007 Jul; 2006(2):CD000304. PubMed ID: 17636627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydergine for dementia.
    Olin J; Schneider L; Novit A; Luczak S
    Cochrane Database Syst Rev; 2001; (2):CD000359. PubMed ID: 11405961
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
    Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
    Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nimodipine for primary degenerative, mixed and vascular dementia.
    López-Arrieta JM; Birks J
    Cochrane Database Syst Rev; 2002; (3):CD000147. PubMed ID: 12137606
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA; Legault C; Kuller L; Rapp SR; Thal L; Lane DS; Fillit H; Stefanick ML; Hendrix SL; Lewis CE; Masaki K; Coker LH;
    JAMA; 2004 Jun; 291(24):2947-58. PubMed ID: 15213206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rivastigmine for vascular cognitive impairment.
    Birks J; McGuinness B; Craig D
    Cochrane Database Syst Rev; 2013 May; (5):CD004744. PubMed ID: 23728651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins for the treatment of dementia.
    McGuinness B; O'Hare J; Craig D; Bullock R; Malouf R; Passmore P
    Cochrane Database Syst Rev; 2010 Aug; (8):CD007514. PubMed ID: 20687089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Piracetam for dementia or cognitive impairment.
    Flicker L; Grimley Evans J
    Cochrane Database Syst Rev; 2000; (2):CD001011. PubMed ID: 10796585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2001; (1):CD001747. PubMed ID: 11279727
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly.
    Fioravanti M; Yanagi M
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000269. PubMed ID: 15846601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Women's Health Initiative Memory Study: findings and implications for treatment.
    Craig MC; Maki PM; Murphy DG
    Lancet Neurol; 2005 Mar; 4(3):190-4. PubMed ID: 15721829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of blood pressure lowering on development of cognitive impairment and dementia in patients without apparent prior cerebrovascular disease.
    McGuinness B; Todd S; Passmore P; Bullock R
    Cochrane Database Syst Rev; 2006 Apr; (2):CD004034. PubMed ID: 16625595
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The menopause and HRT. HRT and cognitive decline.
    Maki P; Hogervorst E
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):105-22. PubMed ID: 12763515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.